4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone has been researched along with butyric acid in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cohrs, RJ; Prasad, KN; Sharma, OK | 1 |
Prasad, KN; Rama, BN | 1 |
2 other study(ies) available for 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone and butyric acid
Article | Year |
---|---|
Decreased expressions of c-myc and H-ras oncogenes in vitamin E succinate induced morphologically differentiated murine B-16 melanoma cells in culture.
Topics: 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Animals; Butyrates; Butyric Acid; Cell Differentiation; Cyclic AMP; Gene Expression Regulation, Neoplastic; Melanoma, Experimental; Mice; Neoplasm Proteins; Proto-Oncogene Proteins c-myc; Proto-Oncogene Proteins p21(ras); RNA, Messenger; RNA, Neoplasm; Tocopherols; Tretinoin; Tumor Cells, Cultured; Vitamin E | 1990 |
Modification of the hyperthermic response on neuroblastoma cells by cAMP and sodium butyrate.
Topics: 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Animals; Butyrates; Butyric Acid; Cell Line; Cell Survival; Cyclic AMP; Hyperthermia, Induced; Mice; Neuroblastoma; Prostaglandins A | 1986 |